BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8609088)

  • 1. A-72363 A-1, A-2, and C, novel heparanase inhibitors from Streptomyces nobilis SANK 60192, II. Biological activities.
    Kawase Y; Takahashi M; Takatsu T; Arai M; Nakajima M; Tanzawa K
    J Antibiot (Tokyo); 1996 Jan; 49(1):61-4. PubMed ID: 8609088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A-72363 A-1, A-2 and C, novel heparanase inhibitors from Streptomyces nobilis SANK 60192. I. Taxonomy of producing organism, fermentation, isolation and structure elucidation.
    Takatsu T; Takahashi M; Kawase Y; Enokita R; Okazaki T; Matsukawa H; Ogawa K; Sakaida Y; Kagasaki T; Kinoshita T; Nakajima M; Tanzawa K
    J Antibiot (Tokyo); 1996 Jan; 49(1):54-60. PubMed ID: 8609086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trachyspic acid, a new metabolite produced by Talaromyces trachyspermus, that inhibits tumor cell heparanase: taxonomy of the producing strain, fermentation, isolation, structural elucidation, and biological activity.
    Shiozawa H; Takahashi M; Takatsu T; Kinoshita T; Tanzawa K; Hosoya T; Furuya K; Takahashi S; Furihata K; Seto H
    J Antibiot (Tokyo); 1995 May; 48(5):357-62. PubMed ID: 7797435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-alkyl-3-decarboxy-3-hydroxymethylsiastatin B, a new family of glycosidase inhibitors of gem-diamine 1-N-iminosugars.
    Kondo KI; Adachi H; Nishimura Y; Takeuchi T
    Nat Prod Lett; 2001; 15(6):371-5. PubMed ID: 11838974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Totally synthetic analogues of siastatin B. II. Optically active piperidine derivatives having trifluoroacetamide and hydroxyacetamide groups at C-2.
    Nishimura Y; Kudo T; Kondo S; Takeuchi T
    J Antibiot (Tokyo); 1992 Jun; 45(6):963-70. PubMed ID: 1500364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Basis for Inhibition of Heparanases and β-Glucuronidases by Siastatin B.
    Chen Y; van den Nieuwendijk AMCH; Wu L; Moran E; Skoulikopoulou F; van Riet V; Overkleeft HS; Davies GJ; Armstrong Z
    J Am Chem Soc; 2024 Jan; 146(1):125-133. PubMed ID: 38118176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Totally synthetic analogues of siastatin B. I. Optically active 2-acetamidopiperidine derivatives.
    Kudo T; Nishimura Y; Kondo S; Takeuchi T
    J Antibiot (Tokyo); 1992 Jun; 45(6):954-62. PubMed ID: 1500363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of the glycosidase inhibitory activity of 5-hydroxy substituted isofagomine analogues.
    Matin MM; Sharma T; Sabharwal SG; Dhavale DD
    Org Biomol Chem; 2005 May; 3(9):1702-7. PubMed ID: 15858653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
    Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
    Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
    Savion N; Disatnik MH; Nevo Z
    J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer cell heparanase activity associated with invasion and metastasis.
    Nicolson GL; Nakajima M; Wakabayashi H; Boyd DD; Diaz D; Irimura T
    Adv Enzyme Regul; 1998; 38():19-32. PubMed ID: 9762344
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides.
    Miao HQ; Elkin M; Aingorn E; Ishai-Michaeli R; Stein CA; Vlodavsky I
    Int J Cancer; 1999 Oct; 83(3):424-31. PubMed ID: 10495437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of basement membrane by prostate tumor heparanase.
    Kosir MA; Wang W; Zukowski KL; Tromp G; Barber J
    J Surg Res; 1999 Jan; 81(1):42-7. PubMed ID: 9889056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suramin. A potent inhibitor of melanoma heparanase and invasion.
    Nakajima M; DeChavigny A; Johnson CE; Hamada J; Stein CA; Nicolson GL
    J Biol Chem; 1991 May; 266(15):9661-6. PubMed ID: 2033058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C2-symmetrical tetrahydroxyazepanes as inhibitors of glycosidases and HIV/FIV proteases.
    Qian X; Morís-Varas F; Fitzgerald MC; Wong CH
    Bioorg Med Chem; 1996 Dec; 4(12):2055-69. PubMed ID: 9022971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of polyhydroxylated piperidines and evaluation as glycosidase inhibitors.
    Tite T; Lallemand MC; Poupon E; Kunesch N; Tillequin F; Gravier-Pelletier C; Le Merrer Y; Husson HP
    Bioorg Med Chem; 2004 Oct; 12(19):5091-7. PubMed ID: 15351392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Totally synthetic analogues of siastatin B. III. Trifluoroacetamide analogues having inhibitory activity for tumor metastasis.
    Nishimura Y; Kudo T; Kondo S; Takeuchi T; Tsuruoka T; Fukuyasu H; Shibahara S
    J Antibiot (Tokyo); 1994 Jan; 47(1):101-7. PubMed ID: 8119851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties.
    Lapierre F; Holme K; Lam L; Tressler RJ; Storm N; Wee J; Stack RJ; Castellot J; Tyrrell DJ
    Glycobiology; 1996 Apr; 6(3):355-66. PubMed ID: 8724143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and glycosidase inhibitory activity of 1-amino-3,6-anhydro-1-deoxy-D-sorbitol derivatives.
    Guillarme S; Behr JB; Bello C; Vogel P; Saluzzo C
    Bioorg Chem; 2010 Apr; 38(2):43-7. PubMed ID: 20060997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells.
    Irimura T; Nakajima M; Nicolson GL
    Biochemistry; 1986 Sep; 25(18):5322-8. PubMed ID: 3768351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.